Foley & Lardner LLP represented TCG Crossover (TCGX) as the lead investor in the $105…
Louis LehotSeptember 17, 2024
Foley & Larder LLP represented TCG Crossover (“TCGX”) as the lead investor in the $127.5…
Louis LehotFebruary 13, 2024
Foley & Larder LLP represented TCG Crossover (“TCGX”) as an investor in the $120 million…
Louis LehotFebruary 13, 2024
Foley & Larder LLP recently represented TCG Crossover (“TCGX”) as a lead investor in the…
Louis LehotFebruary 13, 2024
Foley & Lardner LLP represented TCGX as an investor in the $75 million private placement…
Louis LehotJanuary 24, 2024
Foley & Lardner LLP represented TCGX as co-lead investor in the $150 million Series B…
Louis LehotJanuary 23, 2024
Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals…
Louis LehotJanuary 5, 2024
Originally published in Genetic Engineering News on October 10, 2023. Reprinted with permission. The biotechnology sector has long…
Louis LehotOctober 23, 2023
Partners Louis Lehot and Michael Kirwan published an article in Reuters Legal News titled: “The Importance of…
Louis LehotSeptember 29, 2023